Literature DB >> 1707717

The selectivity of the channel coupled to the 5-HT3 receptor.

J L Yakel1, X M Shao, M B Jackson.   

Abstract

The 5-HT3 receptor is unusual among receptors for biogenic amines in that it is directly coupled to an ion channel that is highly permeable to Na+ and K+. We have studied the permeation properties of this channel in order to achieve a more detailed understanding of its physiological function and to extend the comparison with other ligand gated channels. The 5-HT3 receptor channel is significantly permeable to the organic cations Tris, choline, and N-methyl-glucamine, with permeabilities decreasing with size. The permeability ratios for Tris and choline are similar to those determined for the nicotinic receptor; the permeability ratio for Tris is also similar to that of a non-N-methyl-D-aspartate (non-NMDA) excitatory amino acid receptor. This suggests that the diameters at the narrowest parts of these 3 channels are similar. The Ca2+ permeability of the 5-HT3 receptor channel is relatively low, with an upper bound to PCa/PNa estimated as 0.076. The single channel conductance, as determined by noise analysis, was also relatively low, with a value of 4.4 +/- 0.5 pS. Thus, both the Ca2+ permeability and single channel conductance are lower than those of the nicotinic receptor. In these respects, the 5-HT3 receptor is closer to non-NMDA excitatory amino acid receptors. These results are interpreted in terms of a model of the 5-HT3 receptor channel in which the interior has a lower polarizability, and possibly a greater length, in comparison with the nicotinic acetylcholine receptor channel.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1707717     DOI: 10.1016/0006-8993(90)91793-g

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  20 in total

1.  Blockade of 5-HT3 receptor-mediated currents in dissociated frog sensory neurones by benzoxazine derivative, Y-25130.

Authors:  T Yakushiji; N Akaike
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

2.  Activation and desensitization of the 5-HT3 receptor in a rat glioma x mouse neuroblastoma hybrid cell.

Authors:  J L Yakel; X M Shao; M B Jackson
Journal:  J Physiol       Date:  1991-05       Impact factor: 5.182

3.  Comparative receptor mapping of serotoninergic 5-HT3 and 5-HT4 binding sites.

Authors:  M L López-Rodríguez; M J Morcillo; B Benhamú; M L Rosado
Journal:  J Comput Aided Mol Des       Date:  1997-11       Impact factor: 3.686

4.  Serotonin facilitates GABAergic transmission in the CA1 region of rat hippocampus in vitro.

Authors:  N Ropert; N Guy
Journal:  J Physiol       Date:  1991-09       Impact factor: 5.182

5.  An electrophysiological investigation of the properties of a murine recombinant 5-HT3 receptor stably expressed in HEK 293 cells.

Authors:  C H Gill; J A Peters; J J Lambert
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

6.  Single amino acid substitution affects desensitization of the 5-hydroxytryptamine type 3 receptor expressed in Xenopus oocytes.

Authors:  J L Yakel; A Lagrutta; J P Adelman; R A North
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

7.  Characterization of 5-HT3 receptors of N1E-115 neuroblastoma cells by use of the influx of the organic cation [14C]-guanidinium.

Authors:  H Bönisch; M Barann; J Graupner; M Göthert
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

8.  Selection of distinct conformational states of the 5-HT3 receptor by full and partial agonists.

Authors:  J A van Hooft; H P Vijverberg
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

9.  An electrophysiological investigation of the properties of 5-HT3 receptors of rabbit nodose ganglion neurones in culture.

Authors:  J A Peters; H M Malone; J J Lambert
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

10.  Influence of sodium substitutes on 5-HT-mediated effects at mouse 5-HT3 receptors.

Authors:  M Barann; K Schmidt; M Göthert; B W Urban; H Bönisch
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.